CorAlert is developing an accurate, easy-to-use, noninvasive monitoring device to diagnose heart failure in real time.

Background & Market

Heart failure affects 26 million adults worldwide. Up to 45% of patients admitted to hospitals with heart failure die within one year of admission.

Unfortunately, heart failure is complicated to diagnose. Symptoms are easily misread and misdiagnosed, leading to incorrect treatment. Early diagnosis, in combination with constant monitoring, can save lives.


Founded: September 2016
Stage: Technology development
Investor: The Trendlines Group

CorAlert card
Noninvasive monitoring device for the diagnosis of heart failure


Amir Marmor, CEO